Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jones, Roy W.
Funding for this research was provided by:
Eli Lilly and Company
unspecified valid from 2016-11-25